Cardio-Renal Syndrome: Clinical Trials

82 trials for Cardio-Renal Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed, 15 unknown, 11 recruiting, 11 terminated. 28 Not applicable, 10 Phase 2, 10 Phase 4, 8 Phase 3, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable28Completed 10, Recruiting 5, Not yet recruiting 3, Terminated 3, Unknown 3, Withdrawn 2, Active not recruiting 1, Suspended 1
Phase 210Completed 3, Terminated 3, Withdrawn 2, Recruiting 1, Unknown 1
Phase 410Completed 3, Terminated 3, Unknown 3, Not yet recruiting 1
Phase 38Completed 4, Recruiting 3, Unknown 1
Phase 14Completed 2, Terminated 1, Unknown 1

Follow Cardio-Renal Syndrome: new trials by email Literature Review of Cardio-Renal Syndrome trials Research Report on Cardio-Renal Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimised Cardiovascular and Renal Protection in Patients With Chronic Kidney Disease and Cardiovascular Disease
Multidisciplinary Cardio-Renal Care - Chronic Kidney Disease, Heart Failure With Preserved Ejection Fraction (HFPEF)
Not applicableRecruitingOdense University Hospital5002026-10-012026-10-15
Cardiorenal Syndrome: Characteristics and Prognostic Impact in Advanced Heart Failure
Cardiorenal syndrome follow-up - Advanced Heart Failure, Cardiorenal Syndrome
Not applicableNot yet recruitingHospices Civils de Lyon1002026-09-012026-07-01
Monitoring of the Sympathetic/Vagal Balance Through Multiparametric Analysis of Heart Rate Variability (HRV)
HOLTER ECG monitoring - Diabete Type 2, Heart Failure
Active not recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS1502026-05-202026-09-04
Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study
Finerenone, Spironolactone (drug) - Heart Failure, Diabetic Kidney Disease
Phase 4Not yet recruitingHospital de Messejana Dr. Carlos Alberto Studart Gomes602026-04-012026-05-13
Efficacy and Safety of Compression Boots in Patients With Acute Decompensated Heart Failure.
Pulsatile Compression Boots (PCB) - Acute Decompensated Heart Failure (ADHF)
Not applicableNot yet recruitingOdense University Hospital1002026-01-012026-01-29
Dapagliflozin for Cardio-renal Protection After ICU Discharge
Dapagliflozin 10 MG Oral Tablet [Farxiga], One tablet of placebo of dapagliflozin 10 mg - Heart Failure and Chronic Kidney Disease Post-ICU
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris6002025-12-022026-02-23
French AKI Registry (FAKIR): A Multicenter Study on the In-Hospital Management and Outcomes of Severe Acute Kidney Injury in Nephrology Units
Acute Kidney Injury, Kidney Failure Chronic
Not yet recruitingUniversity Hospital, Strasbourg, France7502025-11-012025-08-14
Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
Selective Cytopheretic Device - Acute on Chronic Systolic Congestive Heart Failure, Cardiorenal Syndrome
Not applicableRecruitingSeaStar Medical202025-10-022026-03-31
Screening of Predictive Biomarkers for Cardiorenal Syndrome
This is an observational Study. - Cardiorenal Syndrome (CRS)
RecruitingHaiyan Pan1502025-09-152026-02-27
Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF Patients
Standardized Basic Drug Therapy for HFrEF with Chronic Kidney Dysfunction, Home-based Personalized Exercise Rehabilitation - Cardiorenal Syndrome
Not applicableRecruitingHaiyan Pan602025-09-152026-02-27
SCD for CRS in Congestive Heart Failure (CHF) (No Left Ventricular Assist Device)
Selective Cytopheretic Device - Heart Failure, Chronic Systolic Heart Failure
Not applicableSuspendedLenar Yessayan102025-09-012024-09-27
The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure
Furosemide 20 Milligrams - Acute Heart Failure, Congestive Heart Failure
Phase 3RecruitingInstituto de Investigación Sanitaria Aragón1682025-03-102025-06-06
The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1
Empagliflozin 10 MG, Placebo - Empagliflozin in Cardiorenal Syndrome Type 1
Phase 2 / Phase 3RecruitingChulalongkorn University2002025-03-012026-06-16
Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults.
Transcatheter edge-to-edge repair (TEER) - Tricuspid Regurgitation, Tricuspid Valve Insufficiency
RecruitingRobert Bosch Medical Center1002025-02-012026-03-11
Effects of a Supervised Training Program on Functional Capacity in Patients With HF and Cardiorenal Syndrome
Supervised aerobic plus strength training - Heart Failure, Cardiorenal Syndrome
Not applicableNot yet recruitingFundación para la Investigación del Hospital Clínico de Valencia262024-10-082024-10-15
Venous Ultrasound Guided Organ Decongestion in Patients Hospitalized with Acute Decompensated Heart Failure
VExUS guided decongestion - Cardiorenal Syndrome, Heart Failure
Not applicableRecruitingOslo University Hospital1802024-09-162024-12-03
Cardio-Renal Registry
Observation - End Stage Renal Disease, Cardio-Renal Syndrome
RecruitingQueen Mary University of London600002024-08-012026-01-07
Feasibility Study to Support Cardiorenal Function in Acute Decompensated Heart Failure With Diuretic Resistance
ModulHeart Support - Heart Failure, Acute Decompensated Heart Failure
Not applicableUnknownPuzzle Medical Devices Inc.52024-08-012024-06-17
Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study
Dapagliflozin - Cardiorenal Syndrome
Phase 2CompletedYale University302024-05-302026-08-13
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Aortix System - Heart Failure, Cardiorenal Syndrome
Not applicableRecruitingProcyrion3202023-08-232026-08-25

Showing 20 of 82. Sign in to see all of them.

Narrower conditions

Heart Failure (30)  ·  Renal Insufficiency, Chronic (13)  ·  Renal Insufficiency (10)  ·  Acute Kidney Injury (9)  ·  Edema (4)  ·  Coronary Artery Disease (3)  ·  Heart Diseases (3)  ·  Heart Failure, Diastolic (3)  ·  Heart Failure, Systolic (3)  ·  Hyperemia (3)  ·  Kidney Failure, Chronic (3)  ·  Metabolic Syndrome (3)  ·  Cardiovascular Diseases (2)  ·  Kidney Diseases (2)

Broader conditions

Female Urogenital Diseases (82)  ·  Female Urogenital Diseases and Pregnancy Complications (82)  ·  Male Urogenital Diseases (82)  ·  Urogenital Diseases (82)  ·  Urologic Diseases (82)  ·  Cardiovascular Diseases (80)  ·  Kidney Diseases (80)  ·  Heart Diseases (79)  ·  Renal Insufficiency (72)  ·  Heart Failure (52)  ·  Pathological Conditions, Signs and Symptoms (25)  ·  Pathologic Processes (20)  ·  Chronic Disease (16)  ·  Disease Attributes (16)  ·  Vascular Diseases (11)

Interventions

Spironolactone (6)  ·  Simendan (4)  ·  Dobutamine (3)  ·  Furosemide (3)  ·  Ultrafiltration (3)  ·  dapagliflozin (3)  ·  Cardiac Surgical Procedures (2)  ·  Chlorthalidone (2)  ·  Diet (2)  ·  Isosorbide Dinitrate (2)  ·  Milrinone (2)  ·  Natriuretic Peptide, Brain (2)  ·  Saline Solution, Hypertonic (2)  ·  iodixanol (2)  ·  Acetazolamide (1)

Sponsors

Hospices Civils de Lyon (4)  ·  Chinese PLA General Hospital (3)  ·  Assiut University (2)  ·  Guangdong Provincial People's Hospital (2)  ·  Haiyan Pan (2)  ·  Hospital Civil de Guadalajara (2)  ·  Odense University Hospital (2)  ·  Procyrion (2)  ·  Triomed AB (2)  ·  University of Giessen (2)  ·  3ive Labs (1)  ·  Ain Shams University (1)  ·  Ankara University (1)  ·  Aspirus Heart and Vascular Institute-Research and Education (1)  ·  Assistance Publique - Hôpitaux de Paris (1)

Countries

United States (17)  ·  China (7)  ·  France (7)  ·  Germany (7)  ·  Canada (3)  ·  Italy (3)  ·  Mexico (3)  ·  Netherlands (3)  ·  Sweden (3)  ·  United Kingdom (3)  ·  Australia (2)  ·  Belgium (2)  ·  Denmark (2)  ·  Georgia (2)  ·  Norway (2)

Top investigators

Dai Yun Chen, MD (2)  ·  Horng H. Chen, M.D. (2)  ·  Shiqun Chen, MS (2)  ·  Abdallah I. Kelany, MD (1)  ·  Abinet Aklilu (1)  ·  Alex Parker, MD (1)  ·  Alexander Kharlamov, M.D. (1)  ·  Alexander Perrish, M.D. (1)  ·  Alexandre Mebazaa, MD-PHD (1)  ·  Anitha Vijayan, M.D. (1)  ·  Ann-Cathrine Johansson, MD, PhD (1)  ·  Branko Braam, MD, PhD (1)  ·  Carlo AJ Gaillard, MD, PhD (1)

Results publications

PMID 27179835, PMID 34979962, PMID 10889132, PMID 11904577, PMID 15769768, PMID 16461840, PMID 19318356, PMID 20383871, PMID 22344775, PMID 22839442, PMID 22989293, PMID 23131078, PMID 23247571, PMID 24464960, PMID 24578332, PMID 24856027, PMID 25543972, PMID 25965717, PMID 26041600, PMID 26685074, PMID 26927285, PMID 26989397, PMID 27592046, PMID 28130379, PMID 28711449, PMID 28785469, PMID 29587582, PMID 30054906, PMID 30369310, PMID 30371304, PMID 30429498, PMID 31074184, PMID 31163974, PMID 31423921, PMID 31630601, PMID 32682713, PMID 33258308, PMID 34172005, PMID 34261129, PMID 34604285, PMID 34660661, PMID 34869651, PMID 34970227, PMID 35133199, PMID 35260308, PMID 35282383, PMID 35310981, PMID 35433884, PMID 35437939, PMID 36791280

NIH funding

R01HL084155 (1), R44HL170779 (1), U01HL084904 (1)